Plain-English translation of NCT07574593 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new implanted sensor system called the FIRE1 NORM™ System, designed to help doctors and patients better manage heart failure by monitoring fluid buildup in the body. The goal is to see if using this sensor—combined with your doctors' guidance and your own daily monitoring—can prevent serious heart failure events and hospitalizations better than standard treatment alone.
Heart failure is a condition where the heart struggles to pump blood effectively, causing fluid to build up in the body and leading to hospitalizations and worsening symptoms. This trial exists because doctors need better tools to catch early warning signs of fluid buildup before it becomes a crisis, so patients can adjust medications quickly and stay out of the hospital.
You likely qualify if…
You likely don't qualify if…
If you're randomly selected for the treatment group, you'll have an implant procedure to place a small sensor and then receive guidance from your care team on how to use daily readings to self-manage your heart failure medications. If you're in the standard care group, you'll continue your usual heart failure treatment with the same guideline-based support. Both groups will have regular follow-up visits to monitor your health and track whether you experience heart failure complications or hospitalizations. The study plans to enroll 800 patients across multiple centers worldwide.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States